Plus Therapeutics

Austin, Texas, USA

Collaborations & Partnerships- R&DCollaborations & Partnerships-LicensingCollaborations & Partnerships-ManufactureProprietary Research & Manufacture Basic Listing

C-Score

29%

Developing Profile

Company Details

Address 4200 Marathon Blvd. Ste. 200, Austin, Texas, TX 78756

Country USA

Sectors Collaborations & Partnerships- R&D, Collaborations & Partnerships-Licensing, Collaborations & Partnerships-Manufacture, Proprietary Research & Manufacture

Telephone +1.210.974.6900

Website Visit Website

Map Open Google Maps

Company Activities

Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Our lead drug candidate, Rhenium-186 Nanoliposome, is being evaluated in the NIH-supported multi-center ReSPECT clinical trials for patients with recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer.

Sectors

Collaborations & Partnerships- R&D

Collaborations & Partnerships-Licensing

Collaborations & Partnerships-Manufacture

Proprietary Research & Manufacture

Category/Key Word(s)

Finished Dosage

Precision Therapeutics

Clinical Development-Pipeline

Radiochemical Sciences

Radiopharmaceuticals

Liposomes

Lipids

Microspheres

Platform Technology-Drug Discovery

Anti-Cancer Products

Oncology Products

Company Contacts

No key contacts have been added to this profile yet.

Company Reviews

No reviews have been added to this profile yet.

Claim This Profile

This is the company profile page for Plus Therapeutics on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

Quick Actions

Save Company Give a Referral Print Profile

Overview Partnerships News Financials Media Locations Blogs